TING WANG-WEINMAN: Open Payments
NPI 1801107842 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$155 in 9 payments from 5 companies in 2025. Trend: 2023 $635 · 2024 $370 · 2025 $155
Food & beverage: $155
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $51 |
| Galderma Laboratories, L.P. | 1 | $21 |
| UCB, Inc. | 1 | $17 |
| KYOWA KIRIN, INC. | 1 | $15 |
Products named: OTEZLA, TALTZ, NEMLUVIO, Bimzelx, POTELIGEO.
Industry payments across KS — which companies pay providers there.
